News & Analysis on Clinical Trial Services & Contract Research And Development
The Generic Pharmaceutical Association (GPhA) has praised the Food and Drug Administration for validating the science of generic biopharmaceuticals and making significant progress in establishing requirements to approve these medicines.
Integra Biosciences has launched the CELLine disposable flask, which harnesses membrane technology that is suitable for recombinant protein expression and high yield monoclonal antibody production.
Bioquell UK has developed the Clarus range of patent protected biodecontamination technology, designed to generate hydrogen peroxide vapour for the surface biodeactivation of micro-organisms such as bacteria, viruses, and fungi.
Affinium Pharmaceuticals announced today it has selected a drug candidate, which may represent a potential breakthrough as the first antibiotic to a newly targeted bacterial pathway in 40 years.
Researchers have presented findings, which go some way in understanding a communication pathway inside of cells that contributes to development of brain and prostate cancers. The discovery may present drug makers with a significant drug target.
DOR BioPharma has announced the initiation of drug design program to identify oral, small molecule drugs to counter the effects of botulinum toxin exposure. Currently, there are no clinically acceptable drugs that either slow or reverse the effects of...
Researchers have built and demonstrated a prototype for a new class of miniature devices to study synthetic cell membranes in an effort to speed the discovery of new drugs for a variety of diseases, including cancer.